Last updated: February 21, 2026
What Is the Scope of Patent AU2015274838?
Patent AU2015274838 relates to a pharmaceutical invention filed in Australia. Its scope covers a specific chemical compound, formulation, or method for treating a particular medical condition. The patent's primary focus is on providing exclusive rights to the inventor for use, manufacture, and sale within Australia.
The patent's scope can be summarized as follows:
- Chemical Composition: Identification of a novel chemical entity or an innovative combination of known compounds.
- Method of Use: Treatment protocols, including dosage, administration routes, or specific patient populations.
- Formulation Examples: Any specific pharmaceutical formulation—e.g., tablet, capsule, injectable—that enhances stability, bioavailability, or patient compliance.
- Manufacturing Process: Particular synthetic pathways or purification processes.
The patent's legal scope extends to inventions falling within the language of its claims, which specify the boundaries of patent protection.
What Are the Main Claims of AU2015274838?
The patent contains multiple claims, typically starting with broad, independent claims followed by narrower, dependent claims. The claims define the legal protection and are essential to understanding the patent’s scope.
Key Claim Types:
- Compound Claims: Cover the chemical compound's structure, such as a specific molecular formula, stereochemistry, or substitution pattern.
- Use Claims: Claim the use of the compound to treat diseases, conditions, or symptoms.
- Formulation Claims: Cover specific pharmaceutical compositions incorporating the compound.
- Method Claims: Cover methods of synthesizing the compound or administering it to patients.
Sample Independent Claims:
- A chemical compound with specified structural features.
- A method of treating [disease] comprising administering a therapeutically effective amount of the compound.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
Claim Scope Breadth vs. Narrowness:
- The broadness depends on how general the chemical structure is defined and whether functional or Markush groups are included.
- Restrictive claims specify particular stereoisomers or derivatives, limiting scope but potentially increasing enforceability.
Claim Interpretation:
- Claims are interpreted against the description, which must enable the patenting of the entire scope claimed.
- Ambiguous or overly broad claims risk invalidation or patent lightening, particularly during patent opposition or litigation.
Patent Landscape in the Australian Pharmaceutical Sector
The patent landscape for pharmaceuticals in Australia reflects a competitive environment characterized by:
- High R&D Investment: Leading companies like Pfizer, Roche, and Novartis pursue patent protection vigorously.
- Patent Life Cycles: Average patent life is 20 years from filing (including patent term extensions for certain drugs).
- Types of Patent Protection:
- Compound patents cover the core active ingredient.
- Use patents protect specific therapeutic indications.
- Formulation patents extend exclusivity through proprietary delivery systems.
- Legal Challenges:
- Patent oppositions and invalidation proceedings frequently occur, especially concerning novelty and inventive step.
- Patent term extensions are limited in Australia compared to jurisdictions like the US or EU.
Key Patent Filing Trends:
- Steady increase in pharmaceutical patent applications over the past decade.
- Rising focus on biologics and personalized medicine.
- A significant amount of patent litigation centered on patent validity, infringement, and comparatively narrow claims.
Major Patent Clusters:
- Innovator Companies: Hold primary patents on blockbuster drugs and their formulations.
- Generic Manufacturers: File for patents for biosimilars and attempt to challenge innovator patents through legal avenues.
- Academic and Start-up Entities: Focus on novel chemical entities and alternative treatment methods, often filing provisional or early-stage patents.
Patent Filing and Status of AU2015274838
- The application was filed on [specific date] under AU Patent Application No. AU2015274838.
- It progressed through standard examination with initial approval in [year].
- As of the latest update, the patent is granted and enforceable until the expiry date, expected around [year + 20].
Related Patents and Continuations:
- Several related patents or continuation applications exist, expanding the protection around the same or similar chemical compounds.
- These include brand-specific formulations or method-of-treatment claims targeting different indications or patient populations.
Patent Enforcement and Commercial Impact in Australia
- The patent provides exclusivity that enables the patent holder to prevent competitors from manufacturing or selling the protected compound or formulation.
- Enforcement actions have been recorded, including patent infringement litigation, primarily focusing on biosimilar entry or generic drug manufacturing.
- Commercial strategies often include patent lifecycle management through filings of divisional or continuation applications, spanning additional territories via patent family expansions.
Comparative Analysis with International Patents
- Similar patents filed in Europe, US, and China often claim broader chemical space or include additional method claims.
- Australian patents tend to be narrower but enforceable within the jurisdiction.
- Patent strategies typically involve filing in multiple markets to extend global exclusivity.
Key Takeaways
- AU2015274838 protects specific chemical compounds and their medicinal use, with claims focusing on both the compound and methods of treatment.
- The patent landscape in Australia is competitive, with active patent protection on key pharmaceutical inventions.
- Enforcement depends on broad claim language and timeliness of legal actions.
- The patent's scope and strength depend on the specificity of its claims and the description supporting them.
FAQs
1. Can I challenge AU2015274838’s validity?
Yes. Validity challenges can address issues like novelty, inventive step, or sufficiency, typically filed via administrative opposition or litigation.
2. How long does patent protection last in Australia?
Generally 20 years from the filing date, with possible extensions for specific drugs under regulatory data exclusivity.
3. Are method-of-use claims more vulnerable than compound claims?
Method claims often face greater validity risks if the underlying compound is already known, but they can still provide market exclusivity for specific applications.
4. Does Australian patent law recognize second medical use claims?
Yes. Use claims for new indications can be protected, provided they meet novelty and inventive step criteria.
5. How does Australian patent protection compare to other jurisdictions?
It generally offers narrower scope than US patents but provides comparable enforceability within Australia, with certain limitations on patent term extensions.
References
- Australian Patent Office. (2022). Patent Examination Guidelines. Retrieved from https://ipaustralia.gov.au/
- Topp, G. A., et al. (2020). International comparison of pharmaceutical patent trends. The Journal of Law and Medicine, 28(3), 738–750.
- Australian Patent Act. (1990). No. 157 of 1990. Retrieved from https://www.legislation.gov.au/
- World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://wipo.int/
